[ad_1]
Synopsis
The pharma inventory with a market capitalisation of greater than Rs 1.97 lakh crore fell from its current 52-week excessive of Rs 966 recorded on 29 April 2022 to Rs 821.75 on 15 June 2022 – that interprets right into a draw back of over 15 per cent.
Solar Pharma, a part of the S&P BSE Sensex index, misplaced momentum after hitting a 52-week excessive in April 2022 and a contemporary brief buildup within the inventory means that the promoting strain may proceed within the close to time period.
The pharma inventory with a market capitalisation of greater than Rs 1.97 lakh crore fell from its current 52-week excessive of Rs 966 recorded on 29 April 2022 to Rs 821.75 on 15 June 2022 – that interprets right into a draw back of over 15 per
BY
ETMarkets.com
Present A Story
Share member-only tales with your mates or household and assist them learn it without cost.
Gifting Restrict Reached!
Hey , no extra tales left so that you can present.
No worries! You’re going to get a restrict of 15 tales subsequent month to share along with your family and friends.
Present This Story
Tales Left!
You’ll be able to present upto 15 tales in a month.
- FONT SIZE
AbcSmall
AbcMedium
AbcGiant
- SAVE
- COMMENT
Already an ET Prime Member? Signal In now
Proceed studying with one among these choices:
Restricted Entry
Free
Login to get entry to some unique tales
& personalised newsletters
Login Now
Limitless Entry
Beginning @ Rs120/month
Get entry to unique tales, professional opinions &
in-depth inventory experiences
Subscribe Now
To learn full story, subscribe to ET Prime
Get Limitless Entry to The Financial Instances
₹34 per week
Billed yearly at
₹2499 ₹1749
Already a Member? Signal In now
Register to learn the total article
You’ve bought this Prime Story as a Free Present
Rs 49 for 1st month
Then Rs. 1,749 per yr
Legitimate solely with UPI, Credit score & Debit Playing cards Autopay
–
![]()
–
–
Subscribe Now
(Bank card necessary)
You’ll be able to cancel your subscription anytime
–
–
–
Subscribe Now
(Pay Utilizing Netbanking/UPI/Debit Card)
Netbanking, Credit score & Debit Card
Subscribe with Google
₹399/month
Month-to-month
PLAN
Billed Quantity ₹399
₹208/month
(Save 49%)
Yearly
PLAN
Billed Quantity ₹2,499
15
Days Trial
+Consists of DocuBay and TimesPrime Membership.
₹150/month
(Save 63%)
2-Yr
PLAN
Billed Quantity ₹3,599
15
Days Trial
+Consists of DocuBay and TimesPrime Membership.
Get ET Prime for simply ₹2499 ₹1749/yr
Already a Member? Signal In now
Why ?
Unique Financial Instances Tales, Editorials & Skilled opinion throughout 20+ sectors
Inventory evaluation. Market Analysis. Trade Developments on 4000+ Shares
Clear expertise with
Minimal Adverts
Remark & Interact with ET Prime group
Unique invitations to Digital Occasions with Trade Leaders
A trusted group of Journalists & Analysts who can greatest filter sign from noise
[ad_2]
Source link

